Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$3.6 - $4.46 $7,956 - $9,856
2,210 Added 17.44%
14,880 $55,000
Q2 2023

Aug 11, 2023

BUY
$3.94 - $5.8 $49,919 - $73,486
12,670 New
12,670 $50,000
Q2 2022

Aug 05, 2022

SELL
$2.73 - $5.61 $30,256 - $62,175
-11,083 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$4.47 - $5.56 $125 - $155
28 Added 0.25%
11,083 $50,000
Q3 2021

Nov 08, 2021

SELL
$4.46 - $7.11 $256,699 - $409,223
-57,556 Reduced 83.89%
11,055 $51,000
Q2 2021

Aug 10, 2021

BUY
$6.05 - $10.09 $353,023 - $588,761
58,351 Added 568.72%
68,611 $471,000
Q2 2020

Aug 07, 2020

BUY
$3.08 - $6.56 $31,600 - $67,305
10,260 New
10,260 $65,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $426M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.